20
Ranbaxy Laboratories Limited New Delhi In, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their significant offerings is Cefadroxil monohydrate, supported by a 'Withdrawn by Holder' Certificate of Suitability (CEP) with the number R1-CEP 1998-019 - Rev 00
This Chemical Type CEP, issued on December 18, 2003, remains in force until March 11, 2004, ensuring its reliability within the pharmaceutical industry.
Substance Number 813 associated with this CEP further emphasizes